Abstract We elucidate the role of late Na ? current (I NaL ) for diastolic intracellular Ca 2? (DCa) accumulation in chronic heart failure (HF). HF was induced in 19 dogs by multiple coronary artery microembolizations; 6 normal dogs served as control. Ca 2? transients were recorded in field-paced (0.25 or 1.5 Hz) fluo-4-loaded ventricular myocytes (VM). I NaL and action potentials were recorded by patch-clamp. Failing VM, but not normal VM, exhibited (1) prolonged action potentials and Ca 2? transients at 0.25 Hz, (2) substantial DCa accumulation at 1.5 Hz, and (3) spontaneous Ca 2? releases, which occurred after 1.5 Hz stimulation trains in *31% cases. Selective I NaL blocker ranolazine (10 lM) or the prototypical Na ? channel blocker tetrodotoxin (2 lM) reversibly improved function of failing VM. The DCa accumulation and the beneficial effect of I NaL blockade were reproduced in silico using an excitation-contraction coupling model. We conclude that I NaL contributes to diastolic Ca 2? accumulation and spontaneous Ca 2? release in HF.
Introduction
Congestive heart failure (HF) is associated with severe abnormalities in both cardiac rhythm and contractile function. While Ca 2? directly triggers contractions in cardiac myocytes, both cell Ca 2? content and dynamics are modulated by Na ? ions [1] . Abnormal Na ? handling and Na ? /Ca 2? interplay in HF are being extensively investigated in order to develop new approaches to the treatment of HF [2] [3] [4] . While the majority of Na ? channels open and inactivate during the action potential (AP) upstroke, some of them reopen during the AP plateau, carrying the socalled late or persistent Na ? current (I NaL ) [5] . We found I NaL in cardiomyocytes of both normal and failing human hearts [6] , and further studies showed that I NaL increases in HF, both in patients and in animal models [5, [7] [8] [9] . Augmented I NaL plays an important role in impaired repolarization of cardiomyocytes of failing hearts [6, 7, [9] [10] [11] [12] [13] .
Previous studies have suggested that during each beat a relatively small, but long lasting, I NaL brings a substantial amount of Na ? into cardiomyocytes, comparable to that carried by a large but very brief transient Na ? current (I NaT ) [9] . The latter is reduced in chronic HF [8, 14, 15] , whereas I NaL is increased; hence, the relative contribution of I NaL to the regulation of intracellular Na ? is expected to increase further in myocytes from failing hearts. Thus I NaL , by altering AP and providing Na ? influx, might be implicated in Na ? -related Ca 2? overload, especially in the context of up-regulated Na ? /Ca 2? exchanger (NCX) in HF [16] [17] [18] ; reduced sarcoplasmic reticulum (SR), Ca 2? ATPase (SERCA), or Ca 2? -pump function; down-regulated Ca 2? -release channel (ryanodine receptor, RyR); and increased SR Ca 2? leak [18] [19] [20] [21] [22] [23] . The increased I NaL by depolarizing the cell membrane and increasing late Na ? influx during AP is likely to facilitate a shift of the NCX operation in HF from the prime forward mode to the reverse mode, i.e., from Ca 2? efflux to Ca 2? entry [24] , thereby contributing to cell Ca 2? accumulation in HF. Abnormal cell Ca 2? accumulation, in turn, worsens both contractility (via diastolic function) and rhythm (via spontaneous Ca 2? releases-triggered delayed after-depolarizations, DADs) [18, 25] . Therefore, inhibition of I NaL could be a potential target to improve function of the failing heart, but this possibility remains largely unexplored. While some prior studies have indeed shown improved diastolic performance due to inhibition of I NaL in different experimental conditions (including in vivo settings), those studies were mainly performed in a normal myocardium using pharmacological I NaL enhancement with toxins or other Na ? channel agonists [26] [27] [28] , as well as expressing LQT-3 syndrome-related mutant Na
? channels with retarded inactivation [29] . The properties of I NaL in HF myocytes are distinctively different [9, 11, 12] from the non-inactivating I Na produced by Na ? channel agonists and mutations in myocytes of normal hearts (NH), not to mention differences in Ca 2? handling. Thus, the role of an augmented I NaL in HF remains to be established.
Using a combination of experimental and numerical modeling approaches, the present study tested the hypothesis that I NaL is indeed a major contributor to the dynamic, Na ? -dependent diastolic Ca 2? (DCa) accumulation in single ventricular myocytes isolated from failing hearts. We used a canine chronic HF model that causes numerous physiological deficiencies similar to those observed in patients with HF [30] . Isolated single ventricular myocytes from failing hearts exhibited abnormal Ca 2? handling, including substantial DCa accumulation at a moderate-high physiological pacing rate of 1.5 Hz, which is deleterious to left ventricular ejection fraction in HF patients [31, 32] . Inhibition of I NaL greatly reduced DCa and substantially decreased the probability of spontaneous Ca 2? releases (SCaRs), a well-known initiation mechanism of DADs and triggered arrhythmia [18, 25] . Our numerical modeling confirmed that I NaL provides a substantial contribution to diastolic cell Ca 2? accumulation observed experimentally. Thus, inhibition of I NaL may suppress a significant portion of the Ca 2? accumulation and decrease occurrence of SCaRs in cardiomyocytes and, thereby, is likely to improve heart contractility and rhythm in HF.
Methods
This study conforms to the guide of the care and use of laboratory animals published by the NIH and was approved by the Institutional Animal Care and Use Committee of the Henry Ford Health System. Our experimental methods, data analysis, theoretical formulations, and calculations are given in the Electronic Supplementary Material (ESM). In brief, chronic HF in dogs was induced by multiple sequential coronary microembolizations. Ca 2? signals were measured in field-stimulated, fluo-4-loaded single ventricular myocytes using a photo-multiplier; electrophysiological recordings were performed using the patch-clamp technique. Ca 2? signals and APs were measured at 35°C and 1.8 mM [Ca 2? ] o , I NaL was measured at room temperature (21-23°C). We used ranolazine (RAN) and tetrodotoxin (TTX) as pharmacological tools. Whereas TTX blocks both I NaT and I NaL equally [9] , RAN blocks I NaL preferentially [13] . RAN is superior to other Class I or III drugs (RAN [ amiodarone [ flecainide [ mexiletine [ lidocaine) [13, [33] [34] [35] [36] at blocking I NaL over I NaT . Furthermore, RAN at the concentration of 10 lM used in the present study (i.e., close to therapeutic range of 2-8 lM) has only minor effects on K ? currents [33] , unlike amiodarone, which has major effects on K ? currents. Concentrations of RAN (10 lM) and TTX (2 lM) were chosen to produce a comparable I NaL inhibition (*1.5 of IC 50 ) based on our previous studies [9, 13] .
Results are expressed as mean ± SEM (if not stated otherwise), and statistical significance was based on P \ 0.05, ANOVA followed by Bonferroni's post-hoc test. To evaluate the probability of the SCaRs we used nonparametric two-tailed Fisher's exact test.
We simulated the effect of selective inhibition of I NaL on DCa accumulation and APs in silico using a modified excitation-contraction (E-C) coupling model of failing canine ventricular myocytes developed previously by Winslow et al. [37] (see details in the ESM).
Results
Minor effects of ranolazine and TTX on intracellular Ca 2? in myocytes from normal heart First we tested the effects of 10 lM RAN and 2 lM TTX in field-stimulated cardiomyocytes of normal dogs on the duration (90%) of Ca 2? transients (CaT 90 ) and accumulation of DCa during a pulse train (see the ESM for definition) (Fig. 1) . Both RAN and TTX only slightly reduced CaT 90 at a low stimulation rate of 0.25 Hz, and these effects were not statistically different (Fig. 1c) . At a high stimulation rate of 1.5 Hz, accumulation of DCa was negligible (a few percent) both in control and under RAN or TTX (Fig. 1b) .
Improvement of intracellular Ca
2? handling in myocytes from failing heart by TTX and ranolazine Ca 2? transients were substantially different in fieldstimulated myocytes of failing compared to normal heart. CaT 90 of failing myocytes was significantly longer, and the CaT had a spike-dome configuration when myocytes were stimulated at a frequency of 0.25 Hz (Fig. 2) . Some failing myocytes exhibited multiple oscillations on top of the ''dome'' (Fig. 2a, upper panel) . Both RAN and TTX improved CaT, as they significantly and reversibly shortened CaT 90 by suppressing the dome phase (Fig. 2c) .
Increasing the stimulation rate to 1.5 Hz markedly increased the DCa level during the pulse train (Fig. 3a, b , upper panels) and induced beat-to-beat CaT alternations in amplitude and duration in all HF myocytes studied (Fig. 3a, upper panel) . Both RAN (Fig. 3a) and TTX ( Fig. 3b ) significantly and reversibly decreased DCa accumulation and eliminated these changes (Fig. 3c ).
Next we determined whether failing myocytes generate SCaRs when subjected to 1.5 Hz trains of stimulation pulses. SCaRs occurred in *31% of instances with a delay of 2.1 ± 0.2 s (n = 17) after the end of the last pulse of the 1.5 Hz train of pulses (Fig. 4a ). SCaRs were absent in myocytes of NH. The SCaR amplitude was comparable to that of CaT within the pulse train (see below) and ranged from 163 to 251 nM (calculation of [Ca 2? ] i is given in the ESM). Both TTX and RAN greatly (*threefold) and reversibly reduced the probability of SCaR occurrence (Fig. 4) . signals just after the 1.5 Hz pulse train a in control and b in the presence of 10 lM ranolazine (RAN). Vertical arrows indicate the last pulse in the train. c RAN significantly and reversibly decreases the rate of SCaR. The probability of SCaR occurrence (bars) was evaluated as the percentage of traces that contained SCaR (similar to that shown in a). In control conditions 18 out of total 58 traces contained SCaR, in TTX it was present in 4 out of total 34 traces, in RAN it was present in 3 out of 31 traces, and after washout it was present in 13 out of total 40 traces. Statistical comparison was performed using two-tailed Fisher's exact tests, and P \ 0.05 was considered to be significant. Data were pooled from 31 to 58 cells Does ranolazine affect SR Ca 2? content and NCX function?
The mechanism for the SCaRs, which are precursors for DADs, is the interplay between the SR Ca 2? load, cytoplasmic [Ca 2? ], and NCX (see for review [25] ). Therefore, in order to further address the mechanism of the beneficial effects of RAN to decrease the probability of SCaR occurrence (Fig. 4) [28] , and the decay time constant was used as an estimate of NCX activity [38] . Figure 5a shows traces of the caffeine-induced Ca 2? transients in the absence (left panel) and presence of RAN (10 lM, right panel). Figure 5b and c shows summary data of the caffeine-induced transient amplitude (SR Ca 2? content) and decay time constant (NCX function). Our data show that the decay kinetics (Fig. 5c ) after RAN application changes insignificantly. Although there was an apparent reduction in SR Ca 2? load (Fig. 5b) , the statistical analysis does not reveal statistically significant difference in caffeine-induced Ca 2? transient amplitude (Fig. 5b) . Therefore, we assumed that RAN affects neither SR Ca 2? load nor NCX function.
Effects of ranolazine on I NaL in myocytes from failing heart
In our previous study we have shown that RAN preferentially blocked I NaL (IC 50 = 6.46 lM, for HF) over I NaT (IC 50 = 294 lM, NH; IC 50 = 244 lM, HF) [13] . The effect of the drug on I NaL kinetics has not been previously studied and thus was examined in the present study. The decay of I NaL was approximated by a double-exponential fit (Eq. 4 in the ESM; see examples in Fig. 5a ) as previously suggested [12] . The fast component (s BM , tens of ms) represents burst mode (BM) and the slow component (s LSM , hundreds of ms) represents late scattered mode (LSM) of late Na ? channel openings [12] . The effect of RAN (10 lM) on I NaL was complex and reversible: the density was reduced (Fig. 6b ) and the drug accelerated decay kinetics of both I NaL components (Fig. 6c, d ).
Effects of ranolazine on action potentials in myocytes from failing heart
The AP shape and its duration, especially the variability of AP duration, play an important role in abnormalities of the E-C coupling in HF. We previously showed that AP duration of ventricular myocytes is prolonged (at low rates) and AP duration variability is increased in this canine HF model and in HF patients compared to NH, and the role of I NaL in the AP duration abnormalities has been suggested [6, 7, 10] . Using the specific I NaL inhibitor RAN allows further investigation of the role of I NaL in AP regulation in HF. Accordingly, we determined the effects of RAN (10 lM) on AP duration and its variability at low and high pacing rates in myocytes from failing hearts. The results of these experiments are summarized in Fig. 7 . At both stimulation rates RAN effectively and reversibly shortened the prolonged APs and abolished the beat-to-beat variability apparent as a large dispersion in the AP duration distribution histograms ( Fig. 7c-h ). For comparison the AP duration and its dispersion in normal dog ventricular myocytes recorded at 0.25 and 1.5 Hz were 337 ± 52 ms (mean ± SD, n = 8 cells) and 303 ± 40 ms (n = 9), respectively (data pooled from the previous publications [7, 9, 13] ).
Numerical evaluation of I NaL and late Na ? influx during action potential plateau and its importance for the diastolic Ca 2? accumulation in HF Based on our experimental data, we performed several numerical estimates to answer three key important questions:
1. What is the time course for I NaL and late Na ? influx (i.e., I NaL integral) during AP plateau?
How much of this Na
? influx could be blocked by 10 lM of RAN? 3. Is late Na ? influx sufficient to account for a major portion of diastolic cell Ca 2? accumulation observed experimentally during the pulse train at 1.5 Hz?
In the first approximation we used experimentally recorded AP traces to simulate Na ? influx dynamics during AP plateau (above -30 mV) at low and high rates of (Fig. 8a, b ) (see formulations in the ESM). Results of these AP-clamp simulations are as follows: Because the model includes RAN-induced steady-state inactivation (SSI) shifts found at the physiological resting potential [13] (see Table 1 in the ESM), it predicts greater inhibition of I NaL and late Na ? influx by RAN in physiological conditions in comparison to the voltage-clamp data obtained from a very low holding potential (compare Figs. 6a, 8c ). More specifically, RAN blocks about 77% of the late Na ? influx during the single AP (from 64.3 to 14.5 fC/pF at low rate and from 50.4 to 11.5 fC/pF at the high rate).
A remarkable portion of late Na ? influx is likely exchanged by NCX for Ca 2? steady state during stimulation at 1.5 Hz (Fig. 3) for the following reasons: (1) NCX function is enhanced in HF [16] [17] [18] , (2) NCX operates in the reverse mode during AP plateau in canine failing myocytes (see Fig. 1f in [37] ) and extrudes 3 Na ? for influx of 1 Ca 2? , and (3) I NaL blockade by RAN substantially reduces DCa (Fig. 3) transport systems. Therefore, we further addressed the role on I NaL in CaD accumulation in silico using our modified version of an established model for pacing-induced dog HF ventricular myocytes that includes all essential components of E-C coupling and Na ? homeostasis [37] . This pacinginduced HF model produces similar remodeling of AP and ionic currents, including the augmented I NaL , found in patients with HF and in our dog HF model [6-9, 37, 39] . The details of the model modification to include I NaL are given in the ESM. The results of our model simulations are shown in Fig. 9 . We applied a train of 11 stimulation pulses in the model and recorded intracellular Ca 2? dynamics and APs in Predicted I NaL and its integral (*late Na ? influx) during the corresponding AP shapes (Eq. 9 in the ESM) c control and when I NaL was set to zero. Our model simulations reproduced DCa accumulation (Fig. 9, upper panel) observed experimentally in failing myocytes (Fig. 3a, b , upper panels). Selective blockade of I NaL in the model (either completely or partially, simulating RAN effect) shortened AP (Fig. 9, lower panel) , and substantially reduced this simulated DCa accumulation similarly to that found in experiment (Figs. 7b-f, 3a, b, middle panels) .
We next calculated the absolute cytosolic free Ca 2? dynamics during stimulation with the rate of 1.5 Hz from the respective Ca 2? signal traces represented originally by F/F 0 values (ESM). The CaT amplitude was 210-325 nM in myocytes from the HF model, i.e., values similar to those reported previously for myocytes from pacinginduced models of HF in dogs [37] (*200 nM, see also Fig. 7e ) or cats [40] (*340 nM). Finally, from our experimental traces (examples in Fig. 3a, b) , we found that during 1.5 Hz pulse trains RAN indeed suppresses the major portion of DCa accumulation, which in absolute terms of [Ca 2? ] ranges from 62 to 98 nM. Thus, both of our numerical simulations closely predict this experimental estimate for substantial DCa accumulation suppression by I NaL inhibition.
Discussion
Using a combination of experimental and numerical modeling studies, we demonstrate at the single cell level that in chronic HF augmented activity of the late Na ? channels exerts both direct electrophysiological effects and indirect effects on intracellular Ca 2? concentration in ventricular myocytes. As discussed in detail below, our findings thus suggest a novel cellular and molecular mechanism contributing to rate-dependent [31, 32] impaired diastolic function (i.e., poor relaxation) and DAD-mediated triggered activity, two major abnormalities associated with chronic HF [2, 18, 41, 42] . As we noted in the Introduction, the previous suggestions about the I NaL -mediated mechanism in HF were based on results obtained in normal myocardium using Anemonia sulcata toxin, ATX-II, to produce persistent I Na [27, 28] . The role of I NaL in these latter studies could be exaggerated because ATX-II caused a fivefold increase in the persistent I Na (Fig. 4a in [28] ), whereas studies in failing human and dog hearts showed I NaL amplitude increases of 30-50% [8, 9] . Specific mechanisms to improve Ca 2? handling and heart contractility by inhibition of late Na ? current
Diastolic Ca 2? accumulation
Previous studies in animal models of HF showed that partial blockade of either total Na ? current by saxitoxin or I NaL by RAN improved contractility of myocytes from failing hearts [6, 13] . The results of the present study support the following specific mechanisms of late Na Figs. 1b and 3b) , Ca 2? alternans (Fig. 3a, upper panel) , and SCaR (Fig. 4) . While the DCa accumulation and Ca 2? alternans can directly impair contractions of individual myocytes, increased rate of SCaRs can further worsen the diastolic cardiac muscle function. Indeed, heterogeneity of diastolic [Ca 2? ] i among cells within myocardial tissue caused by asynchronous SCaRs leads to heterogeneous myofilament activation, the summation of which produces a Ca 2? -dependent component to diastolic tone [43] .
The idea that I NaL and its related Na ? influx cause a dynamic cell Ca 2? accumulation in HF is supported by the following results. We showed that partial blockade of I NaL by RAN or TTX greatly improves Ca 2? handling in failing myocytes specifically; associated with inhibition of I NaL , the DCa accumulation decreased (Fig. 3) , alternans disappeared (Fig. 3a) , and the probability of SCaRs decreased substantially (*threefold) (Fig. 4) . This idea is also supported by recent studies in ventricular muscle strips isolated from end-stage failing human hearts [28] and in myocytes from dog failing hearts [13] , which demonstrated that inhibition of I NaL by RAN significantly reduces frequency-dependent increase in diastolic tension (i.e., diastolic dysfunction) by approximately 30% (in line with our results). Finally, inhibition of I NaL and I NaL -related Na ? influx in silico (both an AP clamp and a complete model of E-C coupling) substantially and selectively suppresses DCa accumulation of the myocytes of failing hearts (Figs. 7, 9 ).
Dynamic Ca
2? cycling abnormalities in failing heart; alternans and spontaneous Ca 2? releases
At a low stimulation rate of 0.25 Hz we also observed an abnormal tonic or dome component of CaT (compare upper panels in Figs. 1a, 2a, b) (first reported in heart ventricular muscle strips from patients with HF [44] ). In addition we found some Ca 2? oscillations at low pacing rates (Fig. 2a  upper panel) and beat-to-beat variations of Ca 2? transients at higher rates of stimulation (Fig. 3a, upper panel) that may be a sign of alternans of intracellular Ca 2? cycling [45] . TTX (middle panels in Fig. 2b) or RAN (middle panels in Fig. 2a ) reversed these abnormalities.
The threshold for SCaR is lower in HF because of reduced SERCA function and increased SR Ca 2? leak [20, 21] in line with observation of SCaRs in our recordings in failing (Fig. 4) but not in normal myocytes (Fig. 1b) . Diastolic SCaRs can initiate DADs via activation of the forward mode NCX inward current, and/or nonselective channels [18, 25] . Previous studies demonstrated that when SCaRs within a cardiomyocyte are sufficiently synchronized (e.g., multifocal Ca 2? waves), the resultant depolarization summates and can be sufficient to trigger a spontaneous AP [43] . The amplitude of SCaRs (F/F 0 *1.55) is close to that of CaT during 1.5 Hz pacing (Fig. 4a) , which could be pro-arrhythmic, especially in the context of up-regulated NCX in HF [16] [17] [18] . Indeed, it has been documented that the threshold amplitude of SCaRs that is sufficient to evoke DADs is almost twofold lower for HF myocytes (*280 nM) compared to that in normal heart (*512 nM) [42] . This threshold is close to the amplitude of SCaRs reported here (*250 nM) (Fig. 4a) . Increased Ca 2? entry is an established mechanism for SCaR from the SR [46] . Thus, the DCa accumulation represents a reasonable mechanism for SCaR after the pulse train in our chronic HF model. The fact that TTX and/or RAN inhibited SCaRs without significantly affecting SR load and NCX function (Fig. 5 ) supports this mechanism (Fig. 4b, c) . On the other hand, small (albeit insignificant) decrease in SR Ca 2? load in the presence of RAN (Fig. 5b) does not completely rule out some involvement of SR load in SCaR occurrence, given the non-linear behavior of the SR (i.e., a relatively small change in load triggers the release) [47] . Also elucidation of possible contributions of changes in AP shape and duration in the improvement of Ca 2? handling, caused by the I NaL reduction shown both experimentally and in silico (Figs. 7, 9 ), merits consideration in future studies.
Predictions in silico
Our model simulations provide quantitative evidence that I NaL accounts for a major portion of diastolic cell Ca 2? accumulation in myocytes (stimulated at rate of 1.5 Hz) measured experimentally. A simplified numerical modeling of I NaL during AP clamp shows that RAN (10 lM) almost completely (by 77%) inhibits late Na ? influx (Fig. 8d) . At the same time we also show that Na ? influx via I NaL can be indeed substantial. Taking into account that NCX operates in the reverse mode during AP in HF [24, 48] and NCX function is enhanced in HF [16] [17] [18] , we reasoned that a large portion of Na ? influx is likely to be the cause of an increase in the dynamic exchanged by the reverse mode NCX for Ca 2? . It is known, for example, that the reverse mode NCX-mediated Ca 2? influx is indeed substantial and may even result in the direct activation of contraction in HF [48] . We estimated that late Na ? influx is sufficient to cause a 72 nM increase in cytosolic [Ca 2? ] via this mechanism. We also tested the effect of I NaL inhibition in in silico simulations of the E-C coupling process including all substantial mechanisms involved in the regulation of the Ca 2? and Na ? homeostasis in HF (Fig. 9) . Our model simulations closely reproduce our experimental results and confirm the importance of I NaL for both the AP duration and the DCa accumulation in failing myocardium.
Physiological significance, clinical relevance
In a recent clinical trial RAN significantly reduced arrhythmias in patients with non ST-segment elevation acute coronary syndrome [49] pointing to a potential clinical relevance of I NaL . The beneficial effect of RAN in these patients can be thus explained, in part, by two mechanisms: (1) improvement of repolarization shown in previous studies [13, 33] and in this study (see Fig. 6 ) and (2) Ca 2? handling associated with a decreased probability of spontaneous releases (shown in this study, Fig. 4 ) and, hence, DADs and their triggered APs (see previous section). Partial inhibition of I NaL by RAN, TTX, or saxitoxin greatly improves repolarization and decreases intrinsic beat-to-beat AP duration variability of failing cardiomyocytes [7, 9, 13] (Fig. 6) . The cellular mechanisms of RAN effects proposed in this study may explain, at least in part, beneficial RAN effects previously reported in whole-animal studies by our group and others. In dogs and rabbits RAN reduced infarct size and Ca 2? overload in response to a regional ischemia-reperfusion [50, 51] . In dogs with coronary microembolizationinduced HF, acute intravenous administration of RAN improved LV systolic function and LV mechanical efficiency without increasing myocardial oxygen consumption and without any increase in heart rate or reduction of systemic blood pressure [52] .
I NaL as a novel therapeutic target
The emerging paradigm with regard to Na ? channels in HF is that I NaT is decreased [8, 14, 15] but simultaneously I NaL is increased [5] . Blockers of I NaT are pro-arrhythmic in HF because they will further slow conduction, thus worsening impulse conduction [53] and thereby facilitating development of re-entry. Hence, transient and late Na ? currents must be treated differently. The new type of ''smart'' drugs should preferentially block I NaL over I NaT [5, 54, 55] . The potential benefits (preventing Ca 2? overload and arrhythmias) of the preferential I NaL blockade can be also expected in hypoxia and ischemia, in which I NaL increase and Na ? -induced Ca 2? overload are major features. In ischemia, accumulation of toxic metabolite lysophosphatidylcholine and reactive oxygen species dramatically increases I NaL [56] [57] [58] . Indeed Na ? channels are critically involved in this process because their blockers or activators reduce or increase Ca 2? overload in these pathological conditions, respectively [59, 60] .
In conclusion, we provide evidence that I NaL and its systolic Na ? influx contribute to the dynamic DCa accumulation and spontaneous release in ventricular myocytes from dog model of chronic HF. Therefore, the results of the present study support the idea that selective blockade of this Na ? current represents a plausible strategy to treat Ca 2? -related diastolic dysfunction and arrhythmia in HF.
